Larvol Delta - Study-to-Test-AKR1C3Activated-Prodrug-OBI3424-OBI3424-in-Patients-With-RelapsedRefractory-TCell-Acute-Lymphoblastic-Leukemia-TALL

OBI-3424 - OBI Pharma

http://clinicaltrials.gov/ct2/show/NCT04315324

Feb 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next